intra cellular receptor.[hide]v • d • eOral antidiabetic amaryl liver diabetes and Insulin analogs (A10)Biguanides MetforminSulfonylureas Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, TolbutamideAlpha-glucosidase inhibitors Acarbose, Miglitol, VogliboseThiazolidinediones (TZD).

Sulphoamides, Chlorampenicol, coumarin and probencid may potentiate the hypoglycemic action of glimepride. Thiazides, other diuretic, phothiazides, thyroid products, oral contraceptives, phenytoin tend to produce more insulin and induced increased activity of peripheral insulin intra cellular receptor.[hide]v • d • amaryl liver diabetes antidiabetic drugs and Insulin analogs (A10)Biguanides MetforminSulfonylureas Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, amaryl liver diabetes inhibitors Acarbose, Miglitol, VogliboseThiazolidinediones (TZD) Pioglitazone, amaryl liver diabetes Rosiglitazone, amaryl liver diabetes Nateglinide, Repaglinide, MitiglinideDipeptidyl peptidase-4 (DPP-4) inhibitors Alogliptin,† Saxagliptin,† Sitagliptin, VildagliptinGlucagon-like peptide-1 analog ExenatideAmylin analog PramlintideInsulin analogs fast acting (Insulin glargine, Insulin detemir)Dual PPAR agonists Aleglitazar†, amaryl liver diabetes Tesaglitazar§.

binding >99.5%Metabolism ?Half life ?Excretion ?Therapeutic considerationsPregnancy cat. ?Legal.